What Is Dysautonomia?
Dysautonomia is a broad term for conditions involving dysfunction of the autonomic nervous system (ANS) — the division of the nervous system that controls involuntary functions such as heart rate, blood pressure, digestion, sweating, body temperature, and bladder function.
The ANS has two main branches: the sympathetic ("fight-or-flight" response — increases heart rate, blood pressure, and adrenaline release) and the parasympathetic ("rest-and-digest" response — slows the heart, stimulates digestion). Dysautonomia can affect one or both branches.
Dysautonomias range from benign and functional forms (such as postural orthostatic tachycardia syndrome — POTS) to serious and potentially fatal forms associated with neurodegenerative diseases (such as multiple system atrophy). Increasing recognition of these conditions has led to more frequent diagnoses and more appropriate treatment.
Autonomic Nervous System
Controls vital involuntary functions: blood pressure, heart rate, digestion, sweating, and temperature.
Diverse Manifestations
Dysautonomia can present as dizziness on standing, tachycardia, digestive changes, heat intolerance, and fatigue.
Multiple Causes
It can be primary (idiopathic or genetic), secondary to diseases such as diabetes, Parkinson disease, and autoimmune diseases, or post-infectious.
Types of Dysautonomia
Dysautonomias encompass a heterogeneous group of conditions. The most useful classification in clinical practice distinguishes primary forms (the ANS is the main target) from secondary forms (autonomic dysfunction as a manifestation of another disease).
MAIN TYPES OF DYSAUTONOMIA
| TYPE | FEATURES | TYPICAL AGE RANGE |
|---|---|---|
| POTS (Postural Orthostatic Tachycardia Syndrome) | Excessive tachycardia on standing (>30 bpm or >120 bpm) without significant hypotension | Young adults, 15-50 years, female predominance (5:1) |
| Neurogenic Orthostatic Hypotension | Drop in systolic BP ≥20 mmHg or diastolic ≥10 mmHg within 3 minutes of standing | Older adults; associated with Parkinson disease, MSA, neuropathy |
| Neurocardiogenic (Vasovagal) Syncope | Fainting from excessive vagal reflex — bradycardia and/or hypotension | Any age; peak in adolescence/young adults |
| Pure Autonomic Failure | Severe autonomic dysfunction without other neurologic signs | Middle-aged/older adults |
| Multiple System Atrophy | Dysautonomia + parkinsonism and/or cerebellar ataxia | Over 50 years |
| Post-infectious/Post-COVID Dysautonomia | Autonomic dysfunction after viral infection; frequently POTS | Any age |
Pathophysiology
The pathophysiology varies according to the type of dysautonomia. In POTS, the proposed mechanisms include hypovolemia (reduced blood volume), partial autonomic neuropathy (peripheral sympathetic denervation), central sympathetic hyperactivity, and autoimmunity against adrenergic or muscarinic receptors.
In neurogenic orthostatic hypotension, there is failure of reflex vasoconstriction on assuming the upright position. Normally, on standing, gravitational pooling of blood in the lower limbs (500-700 mL) triggers sympathetic activation with vasoconstriction and increased heart rate. In dysautonomia, this response is inadequate, causing a drop in cerebral blood pressure and symptoms of hypoperfusion.
Post-infectious POTS gained prominence with the COVID-19 pandemic. The proposed mechanism involves small-fiber autonomic neuropathy induced by inflammation, production of autoantibodies against components of the ANS, and microcirculatory dysfunction. Studies demonstrate reduced density of intraepidermal nerve fibers in skin biopsies of patients with POTS.
Symptoms
Symptoms of dysautonomia reflect dysfunction of the functions controlled by the ANS. The presentation varies greatly depending on the type, but orthostatic intolerance — symptoms that arise or worsen in the upright position and improve when lying down — is the most unifying finding.
Symptoms of Dysautonomia
- 01
Dizziness and presyncope on standing
Sensation of "blacking out", darkening or blurred vision when standing up. May progress to syncope (fainting) without adequate compensation.
- 02
Inappropriate tachycardia
Excessive increase in heart rate on standing (>30 bpm or >120 bpm in POTS). May be accompanied by palpitations and chest discomfort.
- 03
Severe fatigue
Profound tiredness disproportionate to the level of activity. One of the most disabling symptoms, especially in POTS.
- 04
Exercise intolerance
Disproportionate tachycardia, dyspnea, and fatigue with minimal exertion. Paradoxically, supervised exercise is part of treatment.
- 05
Gastrointestinal symptoms
Nausea, abdominal distension, early satiety, constipation, or diarrhea. Gastroparesis in severe cases.
- 06
Sweating changes
Hyperhidrosis (excess sweating) or anhidrosis (absence of sweating). May be regional or generalized.
- 07
Heat intolerance
Significant worsening of symptoms in hot environments, since heat causes vasodilation that aggravates hypotension.
- 08
Cognitive dysfunction ("brain fog")
Difficulty concentrating, slowing of thought, memory lapses. Probably related to cerebral hypoperfusion.
Diagnosis
The diagnosis of dysautonomia requires careful clinical assessment and specific autonomic tests. The most accessible test is the active orthostatic test (measurement of BP and HR in supine position and at 1, 3, 5, and 10 minutes of standing). The tilt-table test is the most formal examination for orthostatic intolerance.
🏥Diagnostic Criteria
Fonte: American Autonomic Society Consensus
POTS
Hemodynamic criteria + clinical symptoms- 1.Sustained increase in HR ≥30 bpm (≥40 bpm in 12-19 years) within the first 10 minutes of standing
- 2.OR sustained HR ≥120 bpm
- 3.Without significant orthostatic hypotension (systolic BP does not drop >20 mmHg)
- 4.Symptoms of orthostatic intolerance present for ≥6 months
- 5.Exclusion of other causes: dehydration, medications, hyperthyroidism
Orthostatic Hypotension
- 1.Drop in systolic BP ≥20 mmHg OR diastolic ≥10 mmHg
- 2.Within 3 minutes of standing
- 3.Neurogenic: without adequate compensatory tachycardia
- 4.Non-neurogenic: compensatory tachycardia present (dehydration, medications)
Complementary Tests
- 1.Tilt-table test: formal assessment of the response to standing (70° for 45 min)
- 2.Quantitative sudomotor axon reflex test (QSART): sudomotor function
- 3.Heart rate variability (HRV): sympathetic-vagal balance
- 4.Plasma catecholamines in supine and standing
- 5.Skin biopsy for intraepidermal nerve fibers
WORKUP FOR SECONDARY CAUSES
| TEST | CONDITION INVESTIGATED |
|---|---|
| HbA1c, fasting glucose | Diabetes mellitus (diabetic autonomic neuropathy) |
| TSH | Thyroid disorders |
| Vitamin B12 | B12 deficiency |
| Autonomic antibodies (ganglionic AChR) | Autoimmune autonomic ganglionopathy |
| Protein electrophoresis, free light chains | Amyloidosis |
| Brain MRI | Multiple system atrophy, central lesions |
Differential Diagnosis
Dysautonomia presents with nonspecific symptoms such as dizziness, palpitations, and orthostatic intolerance, which also occur in several other conditions. Precise differentiation is fundamental for correct treatment, especially when there are treatable secondary causes or conditions of different prognosis.
DIAGNÓSTICO DIFERENCIAL
Diagnóstico Diferencial
Drug-Induced Orthostatic Hypotension
Drop in BP on standing with a clear temporal relationship to the start or dose increase of antihypertensives, antidepressants, antipsychotics, or diuretics. Resolution with adjustment or discontinuation of the drug.
Testes Diagnósticos
- Detailed medication history
- Orthostatic test before and after medication adjustment
Parkinson Disease
Leia mais →Autonomic dysfunction (orthostatic hypotension, constipation, erectile dysfunction) present in early stages before classic motor signs. Resting tremor, rigidity, and bradykinesia complete the picture.
Testes Diagnósticos
- Complete neurologic examination
- DaTscan (SPECT with ioflupane)
- MRI to exclude other causes
Multiple System Atrophy (MSA)
Severe autonomic dysfunction combined with parkinsonian and/or cerebellar and/or pyramidal signs. Severe orthostatic hypotension, early and pronounced bladder and erectile dysfunction. Faster and more severe course than Parkinson disease.
- MSA has a worse prognosis — differentiation is important
Testes Diagnósticos
- Brain MRI (putaminal and cerebellar atrophy, "hot cross bun" sign)
- Formal autonomic testing
- QSART
Diabetes Mellitus with Autonomic Neuropathy
Cardiovascular autonomic dysfunction (orthostatic hypotension, resting tachycardia, fixed HR), gastrointestinal (gastroparesis, nocturnal diarrhea), and urogenital dysfunction in a patient with long-standing diabetes or inadequate glycemic control.
Testes Diagnósticos
- Glucose, HbA1c, C-peptide
- Cardiovascular autonomic tests (Valsalva maneuver, HR variation with deep breathing)
- Electromyography
POTS (Postural Orthostatic Tachycardia Syndrome)
Specific subtype of dysautonomia with excessive tachycardia on standing without a significant drop in BP. Predominantly affects young women; symptoms include palpitations, dizziness, "brain fog", fatigue, and syncope on standing.
Testes Diagnósticos
- Active orthostatic test or tilt-table test (criterion: HR increase ≥30 bpm within the first 10 min of standing)
- Exclusion of hyperthyroidism, pheochromocytoma, and dehydration
Secondary Causes That Must Not Be Missed
Before establishing a diagnosis of primary dysautonomia, it is essential to exclude treatable secondary causes. Amyloidosis, Lyme disease, autoimmune autonomic ganglionopathy, paraneoplastic syndrome, and vitamin B12 deficiency can cause reversible autonomic dysfunction if identified early.
Laboratory screening includes HbA1c, TSH, vitamin B12, protein electrophoresis, and autonomic antibodies (anti-ganglionic AChR). In cases with suspicion of a paraneoplastic process — especially in adults with known or suspected malignancy — oncologic workup is mandatory.
Vasovagal Syncope vs. Dysautonomia
Vasovagal syncope is the most common cause of transient loss of consciousness and should be distinguished from structural dysautonomia. In vasovagal syncope, the episode is triggered by specific triggers (pain, heat, emotional stress), preceded by a vegetative prodrome (nausea, pallor, diaphoresis), and rarely associated with chronic symptoms between episodes.
Dysautonomia, on the other hand, tends to cause persistent or recurrent symptoms in response to standing, regardless of emotional triggers. The tilt-table test with provocation testing (isoproterenol or nitroglycerin) can help in differentiation when the clinical picture is ambiguous.
Anxiety and Panic Disorder
Palpitations, dizziness, dyspnea, and a sensation of fainting are symptoms shared between dysautonomia and anxiety disorders. The overlap is real: some patients with POTS develop anxiety secondary to physical discomfort, while in others anxiety can exacerbate autonomic instability.
Differentiation is based on hemodynamic objectification: in dysautonomia, symptoms correlate with measurable changes in HR and BP on standing. The Holter monitor and the tilt-table test are valuable tools to document abnormal autonomic responses and separate organic from functional components.
Treatment
Treatment of dysautonomia is multimodal and individualized. The basis of treatment includes non-pharmacologic measures (volume expansion, graded exercise, counterpressure) and, when necessary, medications to stabilize the cardiovascular response.
Non-pharmacologic Measures
Basis of treatment — continuousIncreased fluid intake (2-3 L/day), salt (6-10 g/day if BP allows), waist-high compression stockings (30-40 mmHg), counterpressure maneuvers (crossing legs, squatting), avoidance of triggers (heat, alcohol, heavy meals), standing up slowly.
Graded Exercise
3-6 month programStart with reclined exercises (recumbent bike, swimming, rowing) and progress gradually to upright exercises. Specific protocols for POTS (such as the Levine/CHOP protocol) show consistent results in studies and are a central part of management alongside other measures.
Pharmacologic Treatment
According to type and severityPOTS: fludrocortisone (volume expander), midodrine (alpha-1 vasoconstrictor), low-dose beta-blocker, ivabradine (tachycardia control). Orthostatic hypotension: fludrocortisone, midodrine, droxidopa.
Treatment of the Cause
When identifiableStrict glycemic control (diabetic neuropathy), immunotherapy (autoimmune ganglionopathy), treatment of the underlying disease (Parkinson disease, amyloidosis, Sjögren syndrome).
Acupuncture as Treatment
Acupuncture has been investigated in dysautonomia for its potential effect on autonomic nervous system modulation. Heart rate variability (HRV) studies suggest that acupuncture can influence the sympathetic-vagal balance, with a tendency toward increased vagal tone and reduction of sympathetic hyperactivity in some populations, although findings vary across studies.
Proposed mechanisms — still under investigation — include stimulation of vagal afferents (particularly the Neiguan point — PC-6), modulation of cardiovascular reflexes through the nuclei of the solitary tract, influence on catecholamine release, and possible improvement of baroreflex function. Electroacupuncture can modulate renal sympathetic activity in experimental models, although clinical translation still requires further studies.
In clinical practice, acupuncture can help in the control of symptoms such as tachycardia, anxiety, digestive disturbances, fatigue, and sleep disorders in patients with dysautonomia. It is a complementary option especially considered in patients with medication intolerance or who seek integrative approaches.
Prognosis
The prognosis varies significantly according to the type of dysautonomia. POTS, especially in young patients, has a generally favorable prognosis: follow-up studies show that 50-80% of patients have significant improvement in 2-5 years, and many achieve remission with exercise and adequate treatment.
Neurogenic orthostatic hypotension associated with neurodegenerative diseases (Parkinson disease, multiple system atrophy) tends to progress with the underlying disease, requiring continuous adjustments in treatment. Diabetic dysautonomia can stabilize or improve with strict glycemic control.
Myths and Facts
Myth vs. Fact
POTS is anxiety — it is 'all psychological'.
POTS is a physiologic condition with documentable autonomic dysfunction on objective tests. The tachycardia is real and measurable, and studies demonstrate neuropathic, autoimmune, and circulating-volume bases. Anxiety can coexist and worsen symptoms, but it is not the cause.
Myth vs. Fact
Patients with dysautonomia should avoid exercise.
Graded exercise is one of the interventions with the best evidence for POTS. Although the start can be difficult (due to exercise intolerance), programs that begin in reclined position and progress gradually show consistent results in the literature and form the basis of non-pharmacologic management, alongside hydration, salt, and counterpressure.
Myth vs. Fact
Fainting once means having dysautonomia.
Isolated vasovagal syncope is extremely common (30% of the population) and does not mean chronic dysautonomia. Dysautonomia is diagnosed when there are recurrent and persistent symptoms of autonomic dysfunction, confirmed by specific tests.
Myth vs. Fact
Drinking a lot of water is enough to treat dysautonomia.
Hydration is an important measure, but treatment of dysautonomia is multimodal. It includes salt, elastic compression, graded exercise, counterpressure maneuvers, and frequently medications. Hydration alone is rarely sufficient.
When to Seek Help
Frequently Asked Questions
Frequently Asked Questions
Dysautonomia is a dysfunction of the autonomic nervous system — the part of the nervous system that controls involuntary functions such as blood pressure, heart rate, digestion, and temperature. It is challenging to diagnose because its symptoms (dizziness, fatigue, palpitations, mental fog) are nonspecific and common to many other conditions. Standard tests are frequently normal, leading patients to consult multiple specialists before receiving the correct diagnosis.
It depends on the cause. Dysautonomias secondary to treatable causes (medications, nutritional deficiencies, autoimmune diseases) can resolve completely with treatment of the underlying cause. Primary forms, such as POTS, frequently improve significantly — especially in young women — with lifestyle measures, graded exercise, and medications. Progressive forms such as multiple system atrophy have a more reserved prognosis.
POTS (postural orthostatic tachycardia syndrome) is a subtype of dysautonomia characterized by an excessive increase in heart rate (≥30 bpm) within the first 10 minutes of standing, without a significant drop in blood pressure. It predominantly affects young women and frequently appears after viral infections (including COVID-19), surgeries, or pregnancy. It is distinguished from orthostatic hypotension, which involves a drop in pressure without necessarily prominent tachycardia.
Yes, physical exercise is one of the pillars of non-pharmacologic treatment of dysautonomia, especially POTS. However, it should be started gradually and supervised, since exercises in the upright position may be poorly tolerated at first. The most studied protocol begins with horizontal exercises (swimming, rowing, recumbent cycling) and progresses gradually to the upright position. A physician should guide individualized progression.
For most patients with dysautonomia without hypertension or heart disease, increased sodium intake (2-4 g/day of sodium, equivalent to 5-10 g of salt) and fluids (2-3 liters/day) is recommended. This helps to expand plasma volume and reduce postural tachycardia and orthostatic hypotension. The exact dose should be individualized by the attending physician, considering comorbidities.
Yes, graduated compression stockings (preferably waist-high, up to 30-40 mmHg) reduce blood pooling in the lower extremities on standing, decreasing the compensatory cardiovascular effort. They are especially useful for patients with orthostatic intolerance and POTS. Abdominal (waist-high) compression garments offer additional benefit compared with conventional knee-high stockings.
Preliminary evidence suggests that medical acupuncture can contribute to modulation of autonomic tone — increasing parasympathetic activity and reducing sympathetic imbalance. Studies using heart rate variability as a biomarker show a consistent modulating effect. A medical acupuncturist can assess whether acupuncture is appropriate as complementary therapy to conventional treatment of dysautonomia.
Yes. The development of POTS and other forms of post-infectious dysautonomia is recognized after various viral infections — and gained renewed attention with the COVID-19 pandemic. So-called "long COVID" includes dysautonomia as one of its most prevalent manifestations. Proposed mechanisms include direct autonomic injury, post-infectious autoimmune response, and endothelial dysfunction.
Pharmacologic treatment varies according to the type of dysautonomia. For POTS and orthostatic hypotension, the most used include: fludrocortisone (retains sodium and water), midodrine (vasoconstrictor), low-dose beta-blockers (for POTS tachycardia), and ivabradine (reduces HR without a pressure effect). The choice should be made by the physician, considering hemodynamic profile, comorbidities, and individual contraindications.
Seek medical evaluation if you have: frequent dizziness on standing with palpitations, recurrent fainting or presyncope, fatigue disproportionate to exertion, heat intolerance, persistent mental fog, or symptoms that worsened after a viral infection. A neurologist or cardiologist can request an orthostatic test and tilt-table test to confirm the diagnosis. Early diagnosis allows initiation of treatment and reduces the functional impact of the condition.
Related Reading
Deepen your knowledge with related articles